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Introduction  
 Something is fundamentally wrong with the medical literature. It’s not just 
that authors misunderstand p values. It’s not that studies are under-powered. 
Misuse of statistics remains common enough but a general uncertainty and 
mistrust appear to have more global roots. Richard Horton, editor-in-chief of The 
Lancet points to “studies with small sample sizes, tiny effects, invalid exploratory 
analyses, and flagrant conflicts of interest.” [1] Horton’s critique remains only one 
of many [1-4], some of which make the case that half of published material may 
be in error [1-2]. Traditional criteria, both from common sense and established 
principles such as Bradford Hill’s criteria [5] are known but disregarded. In my 
view, blame falls on editors whose failure to recognize controversial subjects 
allows de facto (or intentional) bias. Alternative points of view to published 
papers appear in PubPeer, in Letters-to-editors and blogs and social media from 
people with experience and credentials. 
The diet-heart hypothesis. Is there a null hypothesis? 
 Nutrition research remains the most salient problem area in the medical 
literature. Particularly damaging, the diet-heart hypothesis, holds that fat, 
specifically saturated fat, raises total cholesterol or some other lipid fraction that, 
in turn, causes, heart disease. Numerous experimental and clinical attempts to test 
the idea have failed or, more accurately, have succeeded in showing that the 
hypothesis cannot be supported. Negative results, however, have been ignored or 
sometimes cited as if they were supportive. Many reviews and critiques have 
described a state of poor practice that can only be considered a crisis (e.g. [6-10]). 
Meta-analysis to the rescue. 
 A recent  case that pinpoints an apparent breakdown in standards or, at least, 
questionable peer review, the “Presidential Advisory” from the American Heart 
Association (AHA), claimed that if saturated fat (SF) is replaced with 
polyunsaturated fat (PUFA) benefit of cardiovascular risk will result [11]. 
Contradictory evidence was dismissed. In particular, the Advisory does not cite 
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two large meta-analyses [12-13] of 20 or so studies that show no significant 
association. Instead, the AHA advisory zeroed in on four “core” studies; the rather 
strange meta-analysis is shown in Figure 1.  
 Meta-analysis, in my view, remains highly questionable. Assuming that bigger 
n is always better and that the average of several studies, statistically significant 
or not, will be always be statistically significant, would need strong proof. While 
larger n may mathematically reduce error, common sense says that variability will 
increase and the persistent notion that you are trying to average several wrongs to 
make a right is hard to escape. The AHA paper is particularly unusual. 
 Remarkably, two of the four core studies showed no statistical difference 
between saturated and unsaturated — the statistical rule states that if the error bars 
(horizontal lines in the figure) cross the line for a relative risk (RR) of 1.0, this 
indicates no difference between experimental and controls. The two studies that 
did show statistical differences between SF and PUFA, the Oslo-Heart [14] and 
Finnish  Mental Health studies [15], have been consistently criticized if not 
thoroughly discredited [6-10,16]. In the Finnish Mental Health study, the 
experimental population changed over time. So, a patient admitted in the middle 
of the study might have died before any substantial consumption of the diet.  
 The Oslo-Heart study described a relative risk (RR) of SF vs. UF of 1.19,  or 
odds of 54:46. Weak at best. (How much would you change your eating habits 
Figure 1. Meta-analysis of four “core” trials from the AHA Presidential Advisory. Points to 
the left of RR = 1 line indicate benefit of replacing SF. Error bars that cross the line are 
considered not statistically significant (red symbols). 
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over such odds?) At the same time, the RR for smokers vs non-smokers in the 
study, was found to be 2.2. The authors concluded that “a three-fold greater CHD 
mortality rate is demonstrable among the hypercholesterolemic, hypertensive 
smokers.” (my emphasis). In other words, risk came from conflating the very 
weak effect of fat with the more significant impact of smoking. 
 Produced for the AHA by members of the AHA administration and reviewed 
by an AHA committee, the Presidential Advisory appeared in Circulation, a 
journal published by the AHA. The paper was widely reported and was taken as a 
consensus of experts rather than a particular point of view of a private health 
agency. 
What’s wrong here. 
1. While widely used, meta-analysis is highly questionable. Whether two studies 
are sufficiently similar that the results can be averaged and will always 
improve accuracy remains an untested assumption and has no agreed-upon 
method of testing, More significant, averaging data cannot change bad studies 
into good studies.  
2. Small relative risk cannot be considered significant. For comparison, in 
Bradford Hill’s classic study, the odds ratio (OR) for lung cancer was 20:1 for 
smokers compared to non-smokers. And, in a toxic tort case in a court of law, 
epidemiological data would not be accepted as evidence at less that 2:1.  
3. While not universally codified, it is generally recognized that references to 
alternative points of view are required. Similarly, “Cherry-picking” — 
accepting those studies that support your conclusion and ignoring those that 
don’t — are not acceptable (e.g. [17]). 
Alice has 30 % more money than Bob. Is she rich? 
 Without going into the details of the statistics, in disease states or other 
outcomes where the incidence is low, odds ratio (OR), hazard ratio (HR) and 
relative risk (RR) are roughly the same. The small RR in studies like the Oslo-
Heart Study speak to weak effects by themselves. However, even large relative 
values are almost always misleading. The principle that relative parameters hide 
information — Alice may have more money than Bob but they may both be on 
welfare — has general agreement, but the idea is more common in the breach than 
the observance. Absolute difference in outcome between experimental and 
controls should always be reported [3].  
Red Meat scare. 
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 Pan, et al. [18] studied the effect of red meat consumption on  the incidence of 
type 2 diabetes. Three cohorts were followed, the Health Professionals Follow-Up 
Study, (HPFS) and two results from the  Nurses’ Health Studies (NHS I and NHS 
II).  
 The authors claimed that “red meat intakes were positively associated with 
type 2 diabetes (T2D) risk with HRs of  1.12, 1.32 and 1.14 for unprocessed, 
processed, and total red meat. They concluded that their “results suggest that red 
meat consumption, particularly processed red meat, is associated with an 
increased risk of T2D.”  
What’s wrong with this picture? 
Figure 2. Data from Tables 1 and 2 from Pan, et al. [8]. Subjects in quintile 5 (most red meat 
consumption) are considered to have had a “positive test” by analogy with a diagnostic test. Those 
subjects who developed type 2 diabetes are considered as “true positives.”
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 Although is not immediately obvious, the data for calculating the absolute 
differences in risk are provided in Pan, et al.. Figure 2. shows data for the HPFS. 
Data are arranged in five groups (quintiles) according to red meat consumption. 
Table 1 shows that the number of high red meat eaters (Q5) was 7,247. From 
Table 2, we see that, of these, 655 were diagnosed with diabetes. One could think 
of this analysis as similar to a diagnostic test [3] and we can calculate a positive 
predictive value, the ratio of “true positives” (high red meat and diabetes) to all 
“positives” (everybody in Q5) = 655 / 7,247 = 0.090 or 9 %. Such a low incidence 
provides little support for the authors’ conclusion that red meat consumption 
constitutes a risk for type 2 diabetes. To understand how poorly predictive this is, 
we can calculate the same positive predictive value for the group that consumed 
red meat at the low level (first quintile) = 340 / 7,187  = 0.047 or 4.7 %. The 
difference in risk between extremes of red meat consumption is 4.3 %.  
 Now the difference in absolute risk is very small but it is not zero. It is often 
claimed that if this difference were scaled up to a large population, “thousands of 
lives would be saved.” The assumption is that 4.3 % represents a small, but valid 
number. That would be true if the independent variable, the assignment to 
different quintiles, were reliable, that is, if we have accurate dietary records. In 
fact, “Diet was assessed by validated food-frequency questionnaires, and data 
were updated every 4 y.” Food-questionnaires are, in fact, notably unreliable, 
especially if a point is taken only every four years — and, in the current case, 
“validation” does not mean certification of no error but rather statement of the 
inaccuracy which, as one would expect, is never in the single digit range [19]. 
 The most serious fault of the medical literature rests with acceptance of such 
questionable statistical analysis in the face of contradictory evidence from 
experiment or even common sense. In the thirty years from 1980 to 2010, per 
capita red consumption decreased from 127 lbs. to 106 lbs, while type 2 diabetes 
increased from 5.5 million to 21 million and is even higher now. Such population 
data has to be considered as at least as epidemiologically sound as the cohort 
studies.  While also subject to error, the changes are large while the cohort studies 
provide much smaller effects. 
What’s wrong here. 
1. Statistical analysis does not provide information about biological or clinical 
relevance. Experimenters must defend their interpretation based on 
established science and previous work, that is real outcomes [5].  
2. Relative values hide information. Differences in absolute risk should always 
be shown in addition to OR, HR or RR [3].  
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What can be done? 
1. The publication model of (physical) scientific literature is not appropriate for 
medical studies where there is controversy and where results are more 
tentative. Medical reports require post-publication review or periods of 
tentative acceptance subject to continued public comment [1]. 
2. External universally respected, neutral organizations are needed to codify 
good practice and to adjudicate conflicts. In the mean time…  
3. Editors must recognize controversial MSS and appoint reviewers from both 
sides of the controversy. Failure to do so constitutes de facto (or intentional 
bias). 
References 
1. Horton R: Offline: What is medicine's 5 sigma? The Lancet 2015, 
385:1380. 
2. Ioannidis JP: Why most published research findings are false. PLoS 
Med 2005, 2(8):e124. 
3. Gigerenzer G: Misleading communication of risk. Editors should 
enforce transparent reporting in abstracts. BMJ 2010, 341(c4830). 
4. Feinman RD, Keough SM: Ethics in Medical Research and the Low-
Fat Diet-Heart Hypothesis. Ethics in Biology, Engineering and Medicine 
2014, 5(2):149-159. 
5. Hill AB: The Environment and Disease: Association or Causation? 
Proceedings of the Royal Society of Medicine 1965, 58:295-300. 
6. Ravnskov U, Diamond D, Karatay MC, Miller DW, Okuyama H: No 
scientific support for linking dietary saturated fat to CHD. Br J Nutr 
2012, 107(3):455-457; author reply 458-460. 
7. Ravnskov U: The Cholesterol Myths: Exposing the Fallacy that 
Cholesterol and Saturated Fat Cause Heart Disease. Washington, DC: 
NewTrends Publishing, Inc.; 2000. 
8. Elliott J: Flaws, Fallacies and Facts: Reviewing the Early History of 
the Lipid and Diet/Heart Hypotheses. Food and Nutrition Sciences 
2014, 5:1886-1903. 
9. Taubes G: Good Calories, Bad Calories. New York: Alfred A. Knopf; 
2007. 
6
Journal of Evolution and Health, Vol. 2 [2017], Iss. 3, Art. 10
http://jevohealth.com/journal/vol2/iss3/10
DOI: 10.15310/2334-3591.1069
10. Teicholz N: The Big Fat Surprise. Why Butter, Meat & Cheese Belong in a 
Health Diet. New York: Simon & Schuster; 2014. http://www.ravnskov.nu/
cm/ 
11. Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-
Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG et al: Dietary 
Fats and Cardiovascular Disease: A Presidential Advisory From the 
American Heart Association. Circulation 2017, 136(3):e1-e23. 
12. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of 
prospective cohort studies evaluating the association of saturated fat 
with cardiovascular disease. Am J Clin Nutr 2010, 91(3):535-546. 
13. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser 
GE, Goldbourt U, Hallmans G, Knekt P, Liu S et al: Major types of 
dietary fat and risk of coronary heart disease: a pooled analysis of 11 
cohort studies. Am J Clin Nutr 2009, 89(5):1425-1432. 
14.  Leren P: The Oslo diet-heart study. Eleven-year report. Circulation 1970, 
42(5):935-942. 
15. Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E: 
Cholesterol-lowering diet and mortality from coronary heart-disease. 
Lancet 1972, 2(7792):1418-1419. 
16. Feinman RD: The World Turned Upside Down: The Second Low-
Carbohydrate Revolution. Brooklyn, NY: NMS Press; 2014. 
17. Masic I. The Importance of Proper Citation of References in 
Biomedical Articles. Acta Informatica Medica. 2013;21(3):148-155.  
18. Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Willett WC, Hu 
FB: Red meat consumption and risk of type 2 diabetes: 3 cohorts of 
US adults and an updated meta-analysis. The Am J Clin Nutrition 2011, 
94(4):1088-1096. 
19.  Paul, DR, Rhodes, DG, Kramer, M, Baer, DJ, Rumpler, WV Validation of 
a Food Frequency Questionnaire by Direct Measurement of Habitual 
ad Libitum Food Intake American Journal of Epidemiology 162(8): 
20. Ioannidis JP, Tatsioni A, Karassa FB: Published articles should not be 
dead and buried: introducing research updates. Eur J Clin Invest 2010, 
40(9):767-769. 
7
Feinman: Wrong with Medical Research
Published by Journal of Evolution and Health, 2017
